{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:27:55Z","timestamp":1772119675181,"version":"3.50.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000050","name":"national heart, lung, and blood institute","doi-asserted-by":"publisher","award":["HL113530"],"award-info":[{"award-number":["HL113530"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"national heart, lung, and blood institute","doi-asserted-by":"publisher","award":["HL078825"],"award-info":[{"award-number":["HL078825"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11010-021-04283-2","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T02:02:57Z","timestamp":1637028177000},"page":"431-444","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effect of intravenous cell therapy in rats with old myocardial infarction"],"prefix":"10.1007","volume":"477","author":[{"given":"Xian-Liang","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Wysoczynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna M.","family":"Gumpert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Stowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9160-8614","authenticated-orcid":false,"given":"Roberto","family":"Bolli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"4283_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab135","author":"R Bolli","year":"2021","unstructured":"Bolli R, Solankhi M, Tang XL, Kahlon A (2021) Cell therapy in patients with heart failure: a comprehensive review and emerging concepts. Cardiovasc Res. https:\/\/doi.org\/10.1093\/cvr\/cvab135","journal-title":"Cardiovasc Res"},{"key":"4283_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1139\/cjpp-2020-0406","volume":"99","author":"R Bolli","year":"2021","unstructured":"Bolli R, Tang XL, Guo Y, Li Q (2021) After the storm: an objective appraisal of the efficacy of c-kit+ cardiac progenitor cells in preclinical models of heart disease. Can J Physiol Pharmacol 99:129\u2013139. https:\/\/doi.org\/10.1139\/cjpp-2020-0406","journal-title":"Can J Physiol Pharmacol"},{"key":"4283_CR3","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1161\/circresaha.118.313251","volume":"123","author":"M Wysoczynski","year":"2018","unstructured":"Wysoczynski M, Khan A, Bolli R (2018) New paradigms in cell therapy: repeated dosing, intravenous delivery, immunomodulatory actions, and new cell types. Circ Res 123:138\u2013158. https:\/\/doi.org\/10.1161\/circresaha.118.313251","journal-title":"Circ Res"},{"key":"4283_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00395-011-0180-1","volume":"106","author":"Q Li","year":"2011","unstructured":"Li Q, Guo Y, Ou Q, Chen N, Wu WJ, Yuan F, O\u2019Brien E, Wang T, Luo L, Hunt GN, Zhu X, Bolli R (2011) Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models. Basic Res Cardiol 106:849\u2013864. https:\/\/doi.org\/10.1007\/s00395-011-0180-1","journal-title":"Basic Res Cardiol"},{"key":"4283_CR5","doi-asserted-by":"publisher","first-page":"e96725","DOI":"10.1371\/journal.pone.0096725","volume":"9","author":"KU Hong","year":"2014","unstructured":"Hong KU, Guo Y, Li QH, Cao P, Al-Maqtari T, Vajravelu BN, Du J, Book MJ, Zhu X, Nong Y, Bhatnagar A, Bolli R (2014) c-kit+ Cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart. PLoS ONE 9:e96725. https:\/\/doi.org\/10.1371\/journal.pone.0096725","journal-title":"PLoS ONE"},{"key":"4283_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/circulationaha.109.871905","volume":"121","author":"XL Tang","year":"2010","unstructured":"Tang XL, Rokosh G, Sanganalmath SK, Yuan F, Sato H, Mu J, Dai S, Li C, Chen N, Peng Y, Dawn B, Hunt G, Leri A, Kajstura J, Tiwari S, Shirk G, Anversa P, Bolli R (2010) Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 121:293\u2013305. https:\/\/doi.org\/10.1161\/circulationaha.109.871905","journal-title":"Circulation"},{"key":"4283_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1161\/circheartfailure.115.002210","volume":"8","author":"XL Tang","year":"2015","unstructured":"Tang XL, Rokosh G, Sanganalmath SK, Tokita Y, Keith MC, Shirk G, Stowers H, Hunt GN, Wu W, Dawn B, Bolli R (2015) Effects of intracoronary infusion of escalating doses of cardiac stem cells in rats with acute myocardial infarction. Circ Heart Fail 8:757\u2013765. https:\/\/doi.org\/10.1161\/circheartfailure.115.002210","journal-title":"Circ Heart Fail"},{"key":"4283_CR8","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/CIRCRESAHA.115.307647","volume":"118","author":"XL Tang","year":"2016","unstructured":"Tang XL, Li Q, Rokosh G, Sanganalmath SK, Chen N, Ou Q, Stowers H, Hunt G, Bolli R (2016) Long-term outcome of administration of c-kit(POS) cardiac progenitor cells after acute myocardial infarction: transplanted cells do not become cardiomyocytes, but structural and functional improvement and proliferation of endogenous cells persist for at least one year. Circ Res 118:1091\u20131105. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.307647","journal-title":"Circ Res"},{"key":"4283_CR9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/circresaha.116.308937","volume":"119","author":"Y Tokita","year":"2016","unstructured":"Tokita Y, Tang XL, Li Q, Wysoczynski M, Hong KU, Nakamura S, Wu WJ, Xie W, Li D, Hunt G, Ou Q, Stowers H, Bolli R (2016) Repeated administrations of cardiac progenitor cells are markedly more effective than a single administration: a new paradigm in cell therapy. Circ Res 119:635\u2013651. https:\/\/doi.org\/10.1161\/circresaha.116.308937","journal-title":"Circ Res"},{"key":"4283_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.117.007400","author":"XL Tang","year":"2018","unstructured":"Tang XL, Nakamura S, Li Q, Wysoczynski M, Gumpert AM, Wu WJ, Hunt G, Stowers H, Ou Q, Bolli R (2018) Repeated administrations of cardiac progenitor cells are superior to a single administration of an equivalent cumulative dose. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/jaha.117.007400","journal-title":"J Am Heart Assoc"},{"key":"4283_CR11","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1161\/circulationaha.112.001075","volume":"128","author":"R Bolli","year":"2013","unstructured":"Bolli R, Tang XL, Sanganalmath SK, Rimoldi O, Mosna F, Abdel-Latif A, Jneid H, Rota M, Leri A, Kajstura J (2013) Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation 128:122\u2013131. https:\/\/doi.org\/10.1161\/circulationaha.112.001075","journal-title":"Circulation"},{"key":"4283_CR12","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.jacc.2017.01.048","volume":"69","author":"M Wysoczynski","year":"2017","unstructured":"Wysoczynski M, Guo Y, Moore JBT, Muthusamy S, Li Q, Nasr M, Li H, Nong Y, Wu W, Tomlin AA, Zhu X, Hunt G, Gumpert AM, Book MJ, Khan A, Tang XL, Bolli R (2017) Myocardial reparative properties of cardiac mesenchymal cells isolated on the basis of adherence. J Am Coll Cardiol 69:1824\u20131838. https:\/\/doi.org\/10.1016\/j.jacc.2017.01.048","journal-title":"J Am Coll Cardiol"},{"key":"4283_CR13","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.7150\/thno.41000","volume":"10","author":"JS Heidel","year":"2020","unstructured":"Heidel JS, Fischer AG, Tang XL, Sadri G, Wu WJ, Moisa CR, Stowers H, Sandella N, Wysoczynski M, Uchida S, Moore Iv JB (2020) The effect of cardiogenic factors on cardiac mesenchymal cell anti-fibrogenic paracrine signaling and therapeutic performance. Theranostics 10:1514\u20131530. https:\/\/doi.org\/10.7150\/thno.41000","journal-title":"Theranostics"},{"key":"4283_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00395-018-0710-1","volume":"114","author":"JBT Moore","year":"2018","unstructured":"Moore JBT, Tang XL, Zhao J, Fischer AG, Wu WJ, Uchida S, Gumpert AM, Stowers H, Wysoczynski M, Bolli R (2018) Epigenetically modified cardiac mesenchymal stromal cells limit myocardial fibrosis and promote functional recovery in a model of chronic ischemic cardiomyopathy. Basic Res Cardiol 114:3. https:\/\/doi.org\/10.1007\/s00395-018-0710-1","journal-title":"Basic Res Cardiol"},{"key":"4283_CR15","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1073\/pnas.0405957102","volume":"102","author":"B Dawn","year":"2005","unstructured":"Dawn B, Stein AB, Urbanek K, Rota M, Whang B, Rastaldo R, Torella D, Tang XL, Rezazadeh A, Kajstura J, Leri A, Hunt G, Varma J, Prabhu SD, Anversa P, Bolli R (2005) Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci USA 102:3766\u20133771. https:\/\/doi.org\/10.1073\/pnas.0405957102","journal-title":"Proc Natl Acad Sci USA"},{"key":"4283_CR16","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1161\/01.cir.103.14.1893","volume":"103","author":"Q Li","year":"2001","unstructured":"Li Q, Bolli R, Qiu Y, Tang XL, Guo Y, French BA (2001) Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation 103:1893\u20131898. https:\/\/doi.org\/10.1161\/01.cir.103.14.1893","journal-title":"Circulation"},{"key":"4283_CR17","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1161\/01.res.79.3.424","volume":"79","author":"XL Tang","year":"1996","unstructured":"Tang XL, Qiu Y, Park SW, Sun JZ, Kalya A, Bolli R (1996) Time course of late preconditioning against myocardial stunning in conscious pigs. Circ Res 79:424\u2013434. https:\/\/doi.org\/10.1161\/01.res.79.3.424","journal-title":"Circ Res"},{"key":"4283_CR18","doi-asserted-by":"publisher","first-page":"H1679","DOI":"10.1152\/ajpheart.2000.279.4.H1679","volume":"279","author":"RC Li","year":"2000","unstructured":"Li RC, Ping P, Zhang J, Wead WB, Cao X, Gao J, Zheng Y, Huang S, Han J, Bolli R (2000) PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. Am J Physiol Heart Circ Physiol 279:H1679\u2013H1689. https:\/\/doi.org\/10.1152\/ajpheart.2000.279.4.H1679","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4283_CR19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1161\/01.res.88.5.520","volume":"88","author":"H Takano","year":"2001","unstructured":"Takano H, Bolli R, Black RG Jr, Kodani E, Tang XL, Yang Z, Bhattacharya S, Auchampach JA (2001) A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ Res 88:520\u2013528. https:\/\/doi.org\/10.1161\/01.res.88.5.520","journal-title":"Circ Res"},{"key":"4283_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","volume":"5","author":"RH Lee","year":"2009","unstructured":"Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P, Prockop DJ (2009) Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5:54\u201363. https:\/\/doi.org\/10.1016\/j.stem.2009.05.003","journal-title":"Cell Stem Cell"},{"key":"4283_CR21","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.117.310599","volume":"120","author":"D Luger","year":"2017","unstructured":"Luger D, Lipinski MJ, Westman PC, Glover DK, Dimastromatteo J, Frias JC, Albelda MT, Sikora S, Kharazi A, Vertelov G, Waksman R, Epstein SE (2017) Intravenously delivered mesenchymal stem cells: systemic anti-inflammatory effects improve left ventricular dysfunction in acute myocardial infarction and ischemic cardiomyopathy. Circ Res 120:1598\u20131613. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310599","journal-title":"Circ Res"},{"key":"4283_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00395-005-0521-z","volume":"100","author":"J Ma","year":"2005","unstructured":"Ma J, Ge J, Zhang S, Sun A, Shen J, Chen L, Wang K, Zou Y (2005) Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol 100:217\u2013223. https:\/\/doi.org\/10.1007\/s00395-005-0521-z","journal-title":"Basic Res Cardiol"},{"key":"4283_CR23","doi-asserted-by":"publisher","first-page":"H2670","DOI":"10.1152\/ajpheart.01071.2003","volume":"287","author":"N Nagaya","year":"2004","unstructured":"Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, Uematsu M, Yamagishi M, Mori H, Kangawa K, Kitamura S (2004) Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 287:H2670\u2013H2676. https:\/\/doi.org\/10.1152\/ajpheart.01071.2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4283_CR24","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2217\/rme.10.104","volume":"6","author":"W Wang","year":"2011","unstructured":"Wang W, Jiang Q, Zhang H, Jin P, Yuan X, Wei Y, Hu S (2011) Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model. Regen Med 6:179\u2013190. https:\/\/doi.org\/10.2217\/rme.10.104","journal-title":"Regen Med"},{"key":"4283_CR25","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1161\/circresaha.109.197723","volume":"104","author":"YL Tang","year":"2009","unstructured":"Tang YL, Zhu W, Cheng M, Chen L, Zhang J, Sun T, Kishore R, Phillips MI, Losordo DW, Qin G (2009) Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res 104:1209\u20131216. https:\/\/doi.org\/10.1161\/circresaha.109.197723","journal-title":"Circ Res"},{"key":"4283_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tcm.2012.05.017","volume":"22","author":"R Mazhari","year":"2012","unstructured":"Mazhari R, Hare JM (2012) Translational findings from cardiovascular stem cell research. Trends Cardiovasc Med 22:1\u20136. https:\/\/doi.org\/10.1016\/j.tcm.2012.05.017","journal-title":"Trends Cardiovasc Med"},{"key":"4283_CR27","doi-asserted-by":"publisher","first-page":"H2196","DOI":"10.1152\/ajpheart.01017.2005","volume":"290","author":"MF Berry","year":"2006","unstructured":"Berry MF, Engler AJ, Woo YJ, Pirolli TJ, Bish LT, Jayasankar V, Morine KJ, Gardner TJ, Discher DE, Sweeney HL (2006) Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol 290:H2196\u2013H2203. https:\/\/doi.org\/10.1152\/ajpheart.01017.2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"4283_CR28","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1093\/eurheartj\/ehp265","volume":"30","author":"KH Schuleri","year":"2009","unstructured":"Schuleri KH, Feigenbaum GS, Centola M, Weiss ES, Zimmet JM, Turney J, Kellner J, Zviman MM, Hatzistergos KE, Detrick B, Conte JV, McNiece I, Steenbergen C, Lardo AC, Hare JM (2009) Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart J 30:2722\u20132732. https:\/\/doi.org\/10.1093\/eurheartj\/ehp265","journal-title":"Eur Heart J"},{"key":"4283_CR29","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1001\/jama.2012.25321","volume":"308","author":"JM Hare","year":"2012","unstructured":"Hare JM, Fishman JE, Gerstenblith G, DiFede Velazquez DL, Zambrano JP, Suncion VY, Tracy M, Ghersin E, Johnston PV, Brinker JA, Breton E, Davis-Sproul J, Schulman IH, Byrnes J, Mendizabal AM, Lowery MH, Rouy D, Altman P, Wong Po Foo C, Ruiz P, Amador A, Da Silva J, McNiece IK, Heldman AW, George R, Lardo A (2012) Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 308:2369\u20132379. https:\/\/doi.org\/10.1001\/jama.2012.25321","journal-title":"JAMA"},{"key":"4283_CR30","doi-asserted-by":"publisher","first-page":"e000140","DOI":"10.1161\/jaha.113.000140","volume":"2","author":"AR Williams","year":"2013","unstructured":"Williams AR, Suncion VY, McCall F, Guerra D, Mather J, Zambrano JP, Heldman AW, Hare JM (2013) Durable scar size reduction due to allogeneic mesenchymal stem cell therapy regulates whole-chamber remodeling. J Am Heart Assoc 2:e000140. https:\/\/doi.org\/10.1161\/jaha.113.000140","journal-title":"J Am Heart Assoc"},{"key":"4283_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1161\/circulationaha.112.131110","volume":"127","author":"AR Williams","year":"2013","unstructured":"Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, Suncion V, Morales AR, Da Silva J, Sussman MA, Heldman AW, Hare JM (2013) Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 127:213\u2013223. https:\/\/doi.org\/10.1161\/circulationaha.112.131110","journal-title":"Circulation"},{"key":"4283_CR32","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1093\/eurheartj\/ehv136","volume":"36","author":"AB Mathiasen","year":"2015","unstructured":"Mathiasen AB, Qayyum AA, Jorgensen E, Helqvist S, Fischer-Nielsen A, Kofoed KF, Haack-Sorensen M, Ekblond A, Kastrup J (2015) Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial). Eur Heart J 36:1744\u20131753. https:\/\/doi.org\/10.1093\/eurheartj\/ehv136","journal-title":"Eur Heart J"},{"key":"4283_CR33","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.jacc.2015.08.879","volume":"66","author":"V Karantalis","year":"2015","unstructured":"Karantalis V, Suncion-Loescher VY, Bagno L, Golpanian S, Wolf A, Sanina C, Premer C, Kanelidis AJ, McCall F, Wang B, Balkan W, Rodriguez J, Rosado M, Morales A, Hatzistergos K, Natsumeda M, Margitich I, Schulman IH, Gomes SA, Mushtaq M, DiFede DL, Fishman JE, Pattany P, Zambrano JP, Heldman AW, Hare JM (2015) Synergistic effects of combined cell therapy for chronic ischemic cardiomyopathy. J Am Coll Cardiol 66:1990\u20131999. https:\/\/doi.org\/10.1016\/j.jacc.2015.08.879","journal-title":"J Am Coll Cardiol"},{"key":"4283_CR34","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1089\/scd.2014.0573","volume":"24","author":"SB de Morais","year":"2015","unstructured":"de Morais SB, da Silva LE, Lataro RM, Silva CA, de Oliveira LF, de Carvalho EE, Simoes MV, da Silva ML, Fazan R Jr, Salgado HC (2015) Mesenchymal stem cells improve heart rate variability and baroreflex sensitivity in rats with chronic heart failure. Stem Cells Dev 24:2181\u20132192. https:\/\/doi.org\/10.1089\/scd.2014.0573","journal-title":"Stem Cells Dev"},{"key":"4283_CR35","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1016\/j.jacc.2017.09.036","volume":"70","author":"M Natsumeda","year":"2017","unstructured":"Natsumeda M, Florea V, Rieger AC, Tompkins BA, Banerjee MN, Golpanian S, Fritsch J, Landin AM, Kashikar ND, Karantalis V, Loescher VY, Hatzistergos KE, Bagno L, Sanina C, Mushtaq M, Rodriguez J, Rosado M, Wolf A, Collon K, Vincent L, Kanelidis AJ, Schulman IH, Mitrani R, Heldman AW, Balkan W, Hare JM (2017) A combination of allogeneic stem cells promotes cardiac regeneration. J Am Coll Cardiol 70:2504\u20132515. https:\/\/doi.org\/10.1016\/j.jacc.2017.09.036","journal-title":"J Am Coll Cardiol"},{"key":"4283_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-018-6804-z","author":"SH Kim","year":"2018","unstructured":"Kim SH, Cho JH, Lee YH, Lee JH, Kim SS, Kim MY, Lee MG, Kang WY, Lee KS, Ahn YK, Jeong MH, Kim HS (2018) Improvement in left ventricular function with intracoronary mesenchymal stem cell therapy in a patient with anterior wall ST-segment elevation myocardial infarction. Cardiovasc Drugs Ther. https:\/\/doi.org\/10.1007\/s10557-018-6804-z","journal-title":"Cardiovasc Drugs Ther"},{"key":"4283_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fcell.2016.00078","volume":"4","author":"M Wysoczynski","year":"2016","unstructured":"Wysoczynski M, Dassanayaka S, Zafir A, Ghafghazi S, Long BW, Noble C, DeMartino AM, Brittian KR, Bolli R, Jones SP (2016) A new method to stabilize C-Kit expression in reparative cardiac mesenchymal cells. Front Cell Dev Biol 4:78. https:\/\/doi.org\/10.3389\/fcell.2016.00078","journal-title":"Front Cell Dev Biol"},{"key":"4283_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00395-017-0606-5","volume":"112","author":"Y Guo","year":"2017","unstructured":"Guo Y, Wysoczynski M, Nong Y, Tomlin A, Zhu X, Gumpert AM, Nasr M, Muthusamy S, Li H, Book M, Khan A, Hong KU, Li Q, Bolli R (2017) Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction. Basic Res Cardiol 112:18. https:\/\/doi.org\/10.1007\/s00395-017-0606-5","journal-title":"Basic Res Cardiol"},{"key":"4283_CR39","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s12015-020-10063-0","volume":"17","author":"Y Guo","year":"2021","unstructured":"Guo Y, Nong Y, Li Q, Tomlin A, Kahlon A, Gumpert A, Slezak J, Zhu X, Bolli R (2021) Comparison of one and three intraventricular injections of cardiac progenitor cells in a murine model of chronic ischemic cardiomyopathy. Stem Cell Rev Rep 17:604\u2013615. https:\/\/doi.org\/10.1007\/s12015-020-10063-0","journal-title":"Stem Cell Rev Rep"},{"key":"4283_CR40","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1161\/circresaha.115.306146","volume":"116","author":"E Avolio","year":"2015","unstructured":"Avolio E, Meloni M, Spencer HL, Riu F, Katare R, Mangialardi G, Oikawa A, Rodriguez-Arabaolaza I, Dang Z, Mitchell K, Reni C, Alvino VV, Rowlinson J, Livi U, Cesselli D, Angelini G, Emanueli C, Beltrami AP, Madeddu P (2015) Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair. Circ Res 116:e81-94. https:\/\/doi.org\/10.1161\/circresaha.115.306146","journal-title":"Circ Res"},{"key":"4283_CR41","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1002\/stem.2198","volume":"33","author":"C Cai","year":"2015","unstructured":"Cai C, Guo Y, Teng L, Nong Y, Tan M, Book MJ, Zhu X, Wang XL, Du J, Wu WJ, Xie W, Hong KU, Li Q, Bolli R (2015) Preconditioning human cardiac stem cells with an HO-1 inducer exerts beneficial effects after cell transplantation in the infarcted murine heart. Stem Cells 33:3596\u20133607. https:\/\/doi.org\/10.1002\/stem.2198","journal-title":"Stem Cells"},{"key":"4283_CR42","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1161\/circresaha.113.301202","volume":"113","author":"JM Duran","year":"2013","unstructured":"Duran JM, Makarewich CA, Sharp TE, Starosta T, Zhu F, Hoffman NE, Chiba Y, Madesh M, Berretta RM, Kubo H, Houser SR (2013) Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms. Circ Res 113:539\u2013552. https:\/\/doi.org\/10.1161\/circresaha.113.301202","journal-title":"Circ Res"},{"key":"4283_CR43","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1161\/circulationaha.109.884403","volume":"120","author":"KM Fischer","year":"2009","unstructured":"Fischer KM, Cottage CT, Wu W, Din S, Gude NA, Avitabile D, Quijada P, Collins BL, Fransioli J, Sussman MA (2009) Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase. Circulation 120:2077\u20132087. https:\/\/doi.org\/10.1161\/circulationaha.109.884403","journal-title":"Circulation"},{"key":"4283_CR44","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.scr.2015.10.017","volume":"15","author":"A Kazakov","year":"2015","unstructured":"Kazakov A, Meier T, Werner C, Hall R, Klemmer B, K\u00f6rbel C, Lammert F, Maack C, B\u00f6hm M, Laufs U (2015) C-kit(+) resident cardiac stem cells improve left ventricular fibrosis in pressure overload. Stem Cell Res 15:700\u2013711. https:\/\/doi.org\/10.1016\/j.scr.2015.10.017","journal-title":"Stem Cell Res"},{"key":"4283_CR45","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.jacc.2011.11.029","volume":"59","author":"TS Li","year":"2012","unstructured":"Li TS, Cheng K, Malliaras K, Smith RR, Zhang Y, Sun B, Matsushita N, Blusztajn A, Terrovitis J, Kusuoka H, Marb\u00e1n L, Marb\u00e1n E (2012) Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol 59:942\u2013953. https:\/\/doi.org\/10.1016\/j.jacc.2011.11.029","journal-title":"J Am Coll Cardiol"},{"key":"4283_CR46","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1159\/000490012","volume":"47","author":"W Li","year":"2018","unstructured":"Li W, Lu Y, Han R, Yue Q, Song X, Wang F, Wu R, Hou F, Yang L, Xu L, Zhao R, Hu J (2018) Gremlin2 regulates the differentiation and function of cardiac progenitor cells via the notch signaling pathway. Cell Physiol Biochem 47:579\u2013589. https:\/\/doi.org\/10.1159\/000490012","journal-title":"Cell Physiol Biochem"},{"key":"4283_CR47","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ebiom.2018.05.021","volume":"32","author":"W Ma","year":"2018","unstructured":"Ma W, Ding F, Wang X, Huang Q, Zhang L, Bi C, Hua B, Yuan Y, Han Z, Jin M, Liu T, Yu Y, Cai B, Du Z (2018) By targeting Atg7 MicroRNA-143 mediates oxidative stress-induced autophagy of c-Kit(+) mouse cardiac progenitor cells. EBioMedicine 32:182\u2013191. https:\/\/doi.org\/10.1016\/j.ebiom.2018.05.021","journal-title":"EBioMedicine"},{"key":"4283_CR48","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1159\/000490224","volume":"47","author":"W Ma","year":"2018","unstructured":"Ma W, He F, Ding F, Zhang L, Huang Q, Bi C, Wang X, Hua B, Yang F, Yuan Y, Han Z, Jin M, Liu T, Yu Y, Cai B, Lu Y, Du Z (2018) Pre-treatment with melatonin enhances therapeutic efficacy of cardiac progenitor cells for myocardial infarction. Cell Physiol Biochem 47:1287\u20131298. https:\/\/doi.org\/10.1159\/000490224","journal-title":"Cell Physiol Biochem"},{"key":"4283_CR49","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.jacc.2012.04.047","volume":"60","author":"S Mohsin","year":"2012","unstructured":"Mohsin S, Khan M, Toko H, Bailey B, Cottage CT, Wallach K, Nag D, Lee A, Siddiqi S, Lan F, Fischer KM, Gude N, Quijada P, Avitabile D, Truffa S, Collins B, Dembitsky W, Wu JC, Sussman MA (2012) Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair. J Am Coll Cardiol 60:1278\u20131287. https:\/\/doi.org\/10.1016\/j.jacc.2012.04.047","journal-title":"J Am Coll Cardiol"},{"key":"4283_CR50","doi-asserted-by":"publisher","first-page":"116","DOI":"10.5966\/sctm.2011-0015","volume":"1","author":"BN Oskouei","year":"2012","unstructured":"Oskouei BN, Lamirault G, Joseph C, Treuer AV, Landa S, Da Silva J, Hatzistergos K, Dauer M, Balkan W, McNiece I, Hare JM (2012) Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair. Stem Cells Transl Med 1:116\u2013124. https:\/\/doi.org\/10.5966\/sctm.2011-0015","journal-title":"Stem Cells Transl Med"},{"key":"4283_CR51","doi-asserted-by":"publisher","first-page":"937","DOI":"10.18632\/oncotarget.22946","volume":"9","author":"G Puddighinu","year":"2018","unstructured":"Puddighinu G, D\u2019Amario D, Foglio E, Manchi M, Siracusano A, Pontemezzo E, Cordella M, Facchiano F, Pellegrini L, Mangoni A, Tafani M, Crea F, Germani A, Russo MA, Limana F (2018) Molecular mechanisms of cardioprotective effects mediated by transplanted cardiac ckit(+) cells through the activation of an inflammatory hypoxia-dependent reparative response. Oncotarget 9:937\u2013957. https:\/\/doi.org\/10.18632\/oncotarget.22946","journal-title":"Oncotarget"},{"key":"4283_CR52","doi-asserted-by":"publisher","first-page":"e43922","DOI":"10.1371\/journal.pone.0043922","volume":"7","author":"K Wang","year":"2012","unstructured":"Wang K, Zhao X, Kuang C, Qian D, Wang H, Jiang H, Deng M, Huang L (2012) Overexpression of SDF-1\u03b1 enhanced migration and engraftment of cardiac stem cells and reduced infarcted size via CXCR4\/PI3K pathway. PLoS ONE 7:e43922. https:\/\/doi.org\/10.1371\/journal.pone.0043922","journal-title":"PLoS ONE"},{"key":"4283_CR53","doi-asserted-by":"publisher","first-page":"C358","DOI":"10.1152\/ajpcell.00187.2013","volume":"307","author":"LX Zhang","year":"2014","unstructured":"Zhang LX, DeNicola M, Qin X, Du J, Ma J, Tina Zhao Y, Zhuang S, Liu PY, Wei L, Qin G, Tang Y, Zhao TC (2014) Specific inhibition of HDAC4 in cardiac progenitor cells enhances myocardial repairs. Am J Physiol Cell Physiol 307:C358\u2013C372. https:\/\/doi.org\/10.1152\/ajpcell.00187.2013","journal-title":"Am J Physiol Cell Physiol"},{"key":"4283_CR54","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13287-015-0252-5","volume":"6","author":"YT Zhao","year":"2015","unstructured":"Zhao YT, Du J, Chen Y, Tang Y, Qin G, Lv G, Zhuang S, Zhao TC (2015) Inhibition of Oct 3\/4 mitigates the cardiac progenitor-derived myocardial repair in infarcted myocardium. Stem Cell Res Ther 6:259. https:\/\/doi.org\/10.1186\/s13287-015-0252-5","journal-title":"Stem Cell Res Ther"},{"key":"4283_CR55","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1007\/s00595-013-0528-2","volume":"43","author":"S Alshammary","year":"2013","unstructured":"Alshammary S, Fukushima S, Miyagawa S, Matsuda T, Nishi H, Saito A, Kamata S, Asahara T, Sawa Y (2013) Impact of cardiac stem cell sheet transplantation on myocardial infarction. Surg Today 43:970\u2013976. https:\/\/doi.org\/10.1007\/s00595-013-0528-2","journal-title":"Surg Today"},{"key":"4283_CR56","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cardfail.2017.03.002","volume":"23","author":"L Bao","year":"2017","unstructured":"Bao L, Meng Q, Li Y, Deng S, Yu Z, Liu Z, Zhang L, Fan H (2017) C-Kit positive cardiac stem cells and bone marrow-derived mesenchymal stem cells synergistically enhance angiogenesis and improve cardiac function after myocardial infarction in a paracrine manner. J Card Fail 23:403\u2013415. https:\/\/doi.org\/10.1016\/j.cardfail.2017.03.002","journal-title":"J Card Fail"},{"key":"4283_CR57","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1021\/acsbiomaterials.7b00502","volume":"4","author":"S Bhutani","year":"2018","unstructured":"Bhutani S, Nachlas ALY, Brown ME, Pete T, Johnson CT, Garc\u00eda AJ, Davis ME (2018) Evaluation of hydrogels presenting extracellular matrix-derived adhesion peptides and encapsulating cardiac progenitor cells for cardiac repair. ACS Biomater Sci Eng 4:200\u2013210. https:\/\/doi.org\/10.1021\/acsbiomaterials.7b00502","journal-title":"ACS Biomater Sci Eng"},{"key":"4283_CR58","doi-asserted-by":"publisher","first-page":"e25669","DOI":"10.1371\/journal.pone.0025669","volume":"6","author":"CA Carr","year":"2011","unstructured":"Carr CA, Stuckey DJ, Tan JJ, Tan SC, Gomes RS, Camelliti P, Messina E, Giacomello A, Ellison GM, Clarke K (2011) Cardiosphere-derived cells improve function in the infarcted rat heart for at least 16 weeks\u2013an MRI study. PLoS ONE 6:e25669. https:\/\/doi.org\/10.1371\/journal.pone.0025669","journal-title":"PLoS ONE"},{"key":"4283_CR59","doi-asserted-by":"publisher","first-page":"3536854","DOI":"10.1155\/2018\/3536854","volume":"2018","author":"K Dergilev","year":"2018","unstructured":"Dergilev K, Tsokolaeva Z, Makarevich P, Beloglazova I, Zubkova E, Boldyreva M, Ratner E, Dyikanov D, Menshikov M, Ovchinnikov A, Ageev F, Parfyonova Y (2018) C-Kit cardiac progenitor cell based cell sheet improves vascularization and attenuates cardiac remodeling following myocardial infarction in rats. Biomed Res Int 2018:3536854. https:\/\/doi.org\/10.1155\/2018\/3536854","journal-title":"Biomed Res Int"},{"key":"4283_CR60","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.cell.2013.07.039","volume":"154","author":"GM Ellison","year":"2013","unstructured":"Ellison GM, Vicinanza C, Smith AJ, Aquila I, Leone A, Waring CD, Henning BJ, Stirparo GG, Papait R, Scarf\u00f2 M, Agosti V, Viglietto G, Condorelli G, Indolfi C, Ottolenghi S, Torella D, Nadal-Ginard B (2013) Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell 154:827\u2013842. https:\/\/doi.org\/10.1016\/j.cell.2013.07.039","journal-title":"Cell"},{"key":"4283_CR61","doi-asserted-by":"publisher","DOI":"10.4172\/2157-7633.1000402","author":"C Li","year":"2017","unstructured":"Li C, Matsushita S, Li Z, Guan J, Amano A (2017) c-kit positive cardiac outgrowth cells demonstrate better ability for cardiac recovery against ischemic myopathy. J Stem Cell Res Ther. https:\/\/doi.org\/10.4172\/2157-7633.1000402","journal-title":"J Stem Cell Res Ther"},{"key":"4283_CR62","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1253\/circj.cj-13-0534","volume":"78","author":"T Matsuda","year":"2014","unstructured":"Matsuda T, Miyagawa S, Fukushima S, Kitagawa-Sakakida S, Akimaru H, Horii-Komatsu M, Kawamoto A, Saito A, Asahara T, Sawa Y (2014) Human cardiac stem cells with reduced notch signaling show enhanced therapeutic potential in a rat acute infarction model. Circ J 78:222\u2013231. https:\/\/doi.org\/10.1253\/circj.cj-13-0534","journal-title":"Circ J"},{"key":"4283_CR63","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/stem.3088","volume":"37","author":"JT Maxwell","year":"2019","unstructured":"Maxwell JT, Trac D, Shen M, Brown ME, Davis ME, Chao MS, Supapannachart KJ, Zaladonis CA, Baker E, Li ML, Zhao J, Jacobs DI (2019) Electrical stimulation of pediatric cardiac-derived c-kit(+) progenitor cells improves retention and cardiac function in right ventricular heart failure. Stem Cells 37:1528\u20131541. https:\/\/doi.org\/10.1002\/stem.3088","journal-title":"Stem Cells"},{"key":"4283_CR64","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/stem.1937","volume":"33","author":"S Sharma","year":"2015","unstructured":"Sharma S, Mishra R, Simpson D, Wehman B, Colletti EJ, Deshmukh S, Datla SR, Balachandran K, Guo Y, Chen L, Siddiqui OT, Kaushal S, Kaushal S (2015) Cardiosphere-derived cells from pediatric end-stage heart failure patients have enhanced functional activity due to the heat shock response regulating the secretome. Stem Cells 33:1213\u20131229. https:\/\/doi.org\/10.1002\/stem.1937","journal-title":"Stem Cells"},{"key":"4283_CR65","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1161\/circulationaha.111.084699","volume":"126","author":"DL Simpson","year":"2012","unstructured":"Simpson DL, Mishra R, Sharma S, Goh SK, Deshmukh S, Kaushal S (2012) A strong regenerative ability of cardiac stem cells derived from neonatal hearts. Circulation 126:S46-53. https:\/\/doi.org\/10.1161\/circulationaha.111.084699","journal-title":"Circulation"},{"key":"4283_CR66","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ijcard.2015.01.050","volume":"183","author":"JM Tang","year":"2015","unstructured":"Tang JM, Luo B, Xiao JH, Lv YX, Li XL, Zhao JH, Zheng F, Zhang L, Chen L, Yang JY, Guo LY, Wang L, Yan YW, Pan YM, Wang JN, Li DS, Wan Y, Chen SY (2015) VEGF-A promotes cardiac stem cell engraftment and myocardial repair in the infarcted heart. Int J Cardiol 183:221\u2013231. https:\/\/doi.org\/10.1016\/j.ijcard.2015.01.050","journal-title":"Int J Cardiol"},{"key":"4283_CR67","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1089\/scd.2014.0222","volume":"24","author":"S Vahdat","year":"2015","unstructured":"Vahdat S, Mousavi SA, Omrani G, Gholampour M, Sotoodehnejadnematalahi F, Ghazizadeh Z, Gharechahi J, Baharvand H, Salekdeh GH, Aghdami N (2015) Cellular and molecular characterization of human cardiac stem cells reveals key features essential for their function and safety. Stem Cells Dev 24:1390\u20131404. https:\/\/doi.org\/10.1089\/scd.2014.0222","journal-title":"Stem Cells Dev"},{"key":"4283_CR68","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1038\/cdd.2017.130","volume":"24","author":"C Vicinanza","year":"2017","unstructured":"Vicinanza C, Aquila I, Scalise M, Cristiano F, Marino F, Cianflone E, Mancuso T, Marotta P, Sacco W, Lewis FC, Couch L, Shone V, Gritti G, Torella A, Smith AJ, Terracciano CM, Britti D, Veltri P, Indolfi C, Nadal-Ginard B, Ellison-Hughes GM, Torella D (2017) Adult cardiac stem cells are multipotent and robustly myogenic: c-kit expression is necessary but not sufficient for their identification. Cell Death Differ 24:2101\u20132116. https:\/\/doi.org\/10.1038\/cdd.2017.130","journal-title":"Cell Death Differ"},{"key":"4283_CR69","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.healun.2014.03.006","volume":"33","author":"L Zakharova","year":"2014","unstructured":"Zakharova L, Nural-Guvener H, Feehery L, Popovic S, Nimlos J, Gaballa MA (2014) Retrograde coronary vein infusion of cardiac explant-derived c-Kit+ cells improves function in ischemic heart failure. J Heart Lung Transplant 33:644\u2013653. https:\/\/doi.org\/10.1016\/j.healun.2014.03.006","journal-title":"J Heart Lung Transplant"},{"key":"4283_CR70","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.5966\/sctm.2014-0290","volume":"4","author":"L Zakharova","year":"2015","unstructured":"Zakharova L, Nural-Guvener H, Feehery L, Popovic-Sljukic S, Gaballa MA (2015) Transplantation of epigenetically modified adult cardiac c-Kit+ cells retards remodeling and improves cardiac function in ischemic heart failure model. Stem Cells Transl Med 4:1086\u20131096. https:\/\/doi.org\/10.5966\/sctm.2014-0290","journal-title":"Stem Cells Transl Med"},{"key":"4283_CR71","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.115.002856","author":"Z Zhang","year":"2016","unstructured":"Zhang Z, Yang J, Yan W, Li Y, Shen Z, Asahara T (2016) Pretreatment of cardiac stem cells with exosomes derived from mesenchymal stem cells enhances myocardial repair. J Am Heart Assoc. https:\/\/doi.org\/10.1161\/jaha.115.002856","journal-title":"J Am Heart Assoc"},{"key":"4283_CR72","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1161\/circheartfailure.112.972273","volume":"6","author":"FG Welt","year":"2013","unstructured":"Welt FG, Gallegos R, Connell J, Kajstura J, D\u2019Amario D, Kwong RY, Coelho-Filho O, Shah R, Mitchell R, Leri A, Foley L, Anversa P, Pfeffer MA (2013) Effect of cardiac stem cells on left-ventricular remodeling in a canine model of chronic myocardial infarction. Circ Heart Fail 6:99\u2013106. https:\/\/doi.org\/10.1161\/circheartfailure.112.972273","journal-title":"Circ Heart Fail"},{"key":"4283_CR73","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3727\/096368913x665602","volume":"23","author":"S Kamata","year":"2014","unstructured":"Kamata S, Miyagawa S, Fukushima S, Nakatani S, Kawamoto A, Saito A, Harada A, Shimizu T, Daimon T, Okano T, Asahara T, Sawa Y (2014) Improvement of cardiac stem cell sheet therapy for chronic ischemic injury by adding endothelial progenitor cell transplantation: analysis of layer-specific regional cardiac function. Cell Transplant 23:1305\u20131319. https:\/\/doi.org\/10.3727\/096368913x665602","journal-title":"Cell Transplant"},{"key":"4283_CR74","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1016\/j.jacc.2016.09.925","volume":"68","author":"S Kulandavelu","year":"2016","unstructured":"Kulandavelu S, Karantalis V, Fritsch J, Hatzistergos KE, Loescher VY, McCall F, Wang B, Bagno L, Golpanian S, Wolf A, Grenet J, Williams A, Kupin A, Rosenfeld A, Mohsin S, Sussman MA, Morales A, Balkan W, Hare JM (2016) Pim1 kinase overexpression enhances ckit(+) cardiac stem cell cardiac repair following myocardial infarction in swine. J Am Coll Cardiol 68:2454\u20132464. https:\/\/doi.org\/10.1016\/j.jacc.2016.09.925","journal-title":"J Am Coll Cardiol"},{"key":"4283_CR75","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/j.athoracsur.2017.04.058","volume":"104","author":"B Wehman","year":"2017","unstructured":"Wehman B, Pietris N, Bigham G, Siddiqui O, Mishra R, Li T, Aiello E, Jack G, Wang W, Murthi S, Sharma S, Kaushal S (2017) Cardiac progenitor cells enhance neonatal right ventricular function after pulmonary artery banding. Ann Thorac Surg 104:2045\u20132053. https:\/\/doi.org\/10.1016\/j.athoracsur.2017.04.058","journal-title":"Ann Thorac Surg"},{"key":"4283_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2178","author":"R Bolli","year":"2021","unstructured":"Bolli R, Mitrani RD, Hare JM, Pepine CJ, Perin EC, Willerson JT, Traverse JH, Henry TD, Yang PC, Murphy MP, March KL, Schulman IH, Ikram S, Lee DP, O\u2019Brien C, Lima JA, Ostovaneh MR, Ambale-Venkatesh B, Lewis G, Khan A, Bacallao K, Valasaki K, Longsomboon B, Gee AP, Richman S, Taylor DA, Lai D, Sayre SL, Bettencourt J, Vojvodic RW, Cohen ML, Simpson L, Aguilar D, Loghin C, Moy\u00e9 L, Ebert RF, Davis BR, Simari RD (2021) A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.2178","journal-title":"Eur J Heart Fail"},{"key":"4283_CR77","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1161\/circulationaha.112.092627","volume":"126","author":"AR Chugh","year":"2012","unstructured":"Chugh AR, Beache GM, Loughran JH, Mewton N, Elmore JB, Kajstura J, Pappas P, Tatooles A, Stoddard MF, Lima JA, Slaughter MS, Anversa P, Bolli R (2012) Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 126:S54-64. https:\/\/doi.org\/10.1161\/circulationaha.112.092627","journal-title":"Circulation"},{"key":"4283_CR78","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nm0405-367","volume":"11","author":"M Gnecchi","year":"2005","unstructured":"Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ (2005) Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11:367\u2013368. https:\/\/doi.org\/10.1038\/nm0405-367","journal-title":"Nat Med"},{"key":"4283_CR79","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/circresaha.108.176826","volume":"103","author":"M Gnecchi","year":"2008","unstructured":"Gnecchi M, Zhang Z, Ni A, Dzau VJ (2008) Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103:1204\u20131219. https:\/\/doi.org\/10.1161\/circresaha.108.176826","journal-title":"Circ Res"},{"key":"4283_CR80","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1634\/stemcells.2007-0637","volume":"25","author":"DG Phinney","year":"2007","unstructured":"Phinney DG, Prockop DJ (2007) Concise review: mesenchymal stem\/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair\u2013current views. Stem Cells 25:2896\u20132902. https:\/\/doi.org\/10.1634\/stemcells.2007-0637","journal-title":"Stem Cells"},{"key":"4283_CR81","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/circresaha.117.310710","volume":"120","author":"R Bolli","year":"2017","unstructured":"Bolli R (2017) Repeated cell therapy: a paradigm shift whose time has come. Circ Res 120:1072\u20131074. https:\/\/doi.org\/10.1161\/circresaha.117.310710","journal-title":"Circ Res"},{"key":"4283_CR82","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jamacardio.2016.2225","volume":"1","author":"PK Nguyen","year":"2016","unstructured":"Nguyen PK, Rhee JW, Wu JC (2016) Adult stem cell therapy and heart failure, 2000 to 2016: a systematic review. JAMA Cardiol 1:831\u2013841. https:\/\/doi.org\/10.1001\/jamacardio.2016.2225","journal-title":"JAMA Cardiol"},{"key":"4283_CR83","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","volume":"110","author":"AJ Nauta","year":"2007","unstructured":"Nauta AJ, Fibbe WE (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499\u20133506. https:\/\/doi.org\/10.1182\/blood-2007-02-069716","journal-title":"Blood"},{"key":"4283_CR84","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","volume":"54","author":"JM Hare","year":"2009","unstructured":"Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB Jr., Reisman MA, Schaer GL, Sherman W (2009) A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54:2277\u20132286. https:\/\/doi.org\/10.1016\/j.jacc.2009.06.055","journal-title":"J Am Coll Cardiol"},{"key":"4283_CR85","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ijcard.2006.11.022","volume":"122","author":"RA Boomsma","year":"2007","unstructured":"Boomsma RA, Swaminathan PD, Geenen DL (2007) Intravenously injected mesenchymal stem cells home to viable myocardium after coronary occlusion and preserve systolic function without altering infarct size. Int J Cardiol 122:17\u201328. https:\/\/doi.org\/10.1016\/j.ijcard.2006.11.022","journal-title":"Int J Cardiol"},{"key":"4283_CR86","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00395-008-0741-0","volume":"103","author":"ME Halkos","year":"2008","unstructured":"Halkos ME, Zhao ZQ, Kerendi F, Wang NP, Jiang R, Schmarkey LS, Martin BJ, Quyyumi AA, Few WL, Kin H, Guyton RA, Vinten-Johansen J (2008) Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Basic Res Cardiol 103:525\u2013536. https:\/\/doi.org\/10.1007\/s00395-008-0741-0","journal-title":"Basic Res Cardiol"},{"key":"4283_CR87","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00424-006-0117-y","volume":"453","author":"W Jiang","year":"2006","unstructured":"Jiang W, Ma A, Wang T, Han K, Liu Y, Zhang Y, Dong A, Du Y, Huang X, Wang J, Lei X, Zheng X (2006) Homing and differentiation of mesenchymal stem cells delivered intravenously to ischemic myocardium in vivo: a time-series study. Pflugers Arch 453:43\u201352. https:\/\/doi.org\/10.1007\/s00424-006-0117-y","journal-title":"Pflugers Arch"},{"key":"4283_CR88","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1089\/scd.2006.0089","volume":"16","author":"U Krause","year":"2007","unstructured":"Krause U, Harter C, Seckinger A, Wolf D, Reinhard A, Bea F, Dengler T, Hardt S, Ho A, Katus HA, Kuecherer H, Hansen A (2007) Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart. Stem Cells Dev 16:31\u201337. https:\/\/doi.org\/10.1089\/scd.2006.0089","journal-title":"Stem Cells Dev"},{"key":"4283_CR89","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13287-018-0888-z","volume":"9","author":"M Lim","year":"2018","unstructured":"Lim M, Wang W, Liang L, Han ZB, Li Z, Geng J, Zhao M, Jia H, Feng J, Wei Z, Song B, Zhang J, Li J, Liu T, Wang F, Li T, Li J, Fang Y, Gao J, Han Z (2018) Intravenous injection of allogeneic umbilical cord-derived multipotent mesenchymal stromal cells reduces the infarct area and ameliorates cardiac function in a porcine model of acute myocardial infarction. Stem Cell Res Ther 9:129. https:\/\/doi.org\/10.1186\/s13287-018-0888-z","journal-title":"Stem Cell Res Ther"},{"key":"4283_CR90","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ijcard.2005.07.036","volume":"111","author":"MJ Price","year":"2006","unstructured":"Price MJ, Chou CC, Frantzen M, Miyamoto T, Kar S, Lee S, Shah PK, Martin BJ, Lill M, Forrester JS, Chen PS, Makkar RR (2006) Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties. Int J Cardiol 111:231\u2013239. https:\/\/doi.org\/10.1016\/j.ijcard.2005.07.036","journal-title":"Int J Cardiol"},{"key":"4283_CR91","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/14017430802100280","volume":"43","author":"D Wolf","year":"2009","unstructured":"Wolf D, Reinhard A, Seckinger A, Gross L, Katus HA, Hansen A (2009) Regenerative capacity of intravenous autologous, allogeneic and human mesenchymal stem cells in the infarcted pig myocardium-complicated by myocardial tumor formation. Scand Cardiovasc J 43:39\u201345. https:\/\/doi.org\/10.1080\/14017430802100280","journal-title":"Scand Cardiovasc J"},{"key":"4283_CR92","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","volume":"121","author":"J Bartolucci","year":"2017","unstructured":"Bartolucci J, Verdugo FJ, Gonzalez PL, Larrea RE, Abarzua E, Goset C, Rojo P, Palma I, Lamich R, Pedreros PA, Valdivia G, Lopez VM, Nazzal C, Alcayaga-Miranda F, Cuenca J, Brobeck MJ, Patel AN, Figueroa FE, Khoury M (2017) Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure: a phase 1\/2 randomized controlled trial (RIMECARD trial [randomized clinical trial of intravenous infusion umbilical cord mesenchymal stem cells on cardiopathy]). Circ Res 121:1192\u20131204. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.310712","journal-title":"Circ Res"},{"key":"4283_CR93","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1161\/circresaha.116.309717","volume":"120","author":"J Butler","year":"2017","unstructured":"Butler J, Epstein SE, Greene SJ, Quyyumi AA, Sikora S, Kim RJ, Anderson AS, Wilcox JE, Tankovich NI, Lipinski MJ, Ko YA, Margulies KB, Cole RT, Skopicki HA, Gheorghiade M (2017) intravenous allogeneic mesenchymal stem cells for nonischemic cardiomyopathy: safety and efficacy results of a phase II\u2014a randomized trial. Circ Res 120:332\u2013340. https:\/\/doi.org\/10.1161\/circresaha.116.309717","journal-title":"Circ Res"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04283-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-021-04283-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04283-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:16:12Z","timestamp":1643415372000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-021-04283-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["4283"],"URL":"https:\/\/doi.org\/10.1007\/s11010-021-04283-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-680510\/v1","asserted-by":"object"}]},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]},"assertion":[{"value":"10 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The paper is original and has not been published and is not being considered for publication elsewhere.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}